Appili Therapeutics Inc. (APLI)
TSX
0.01000
0.00 (0.00%)
Closed
Oct 7, 2026
Day's Range
0.010000.01000
52 wk Range
0.005000.0300
Financial Statements - APLI - Appili Therapeutics Inc.
Revenue
244.17K▲ 143.1%
Net Income
-4.24M▼ 61.6%Net Margin -1736.7%
EBITDA
-2.62M▼ 480.4%
Free Cash Flow
-1.33M▼ 254.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 244.17K | 100.44K | 827.40K | 334.17K | 1.39M | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -3.82M | -190.83K | -2.16M | -7.77M | -23.61M | -14.37M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 698.76K | 1.08M | 65.65K | -364.60K | 56.81K | - |
| Pre Tax Income | -4.13M | -2.60M | -3.71M | -9.20M | -25.07M | -14.32M |
| Income Tax | 105.35K | 18.83K | 69.58K | 36.39K | 38.45K | 0 |
| Net Income | -4.24M | -2.62M | -3.78M | -9.24M | -25.11M | -14.32M |
| EPS Basic | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| EPS Diluted | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| Basic Shares Outstanding | 123.71M | 121.26M | 121.26M | 113.73M | 66.73M | 59.17M |
| Diluted Shares Outstanding | 123.71M | 121.26M | 121.26M | 113.73M | 66.73M | 59.17M |
| Ebit | -2.41M | 347.10K | -2.08M | -8.11M | -23.52M | -14.25M |
| Ebitda | -2.62M | 689.72K | -2.13M | -7.73M | -23.56M | -14.24M |
| Net Income Continuous Operations | -4.24M | -2.62M | -3.78M | -9.24M | -25.11M | -14.32M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
